⌘K

Login Start Free

Home/Filings/4/0001628280-24-009745

4//SEC Filing

Erlander Mark 4

Accession 0001628280-24-009745

CIK 0001213037other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 6:39 PM ET

Size

5.7 KB

Accession

0001628280-24-009745

Insider Transaction Report

Form 4

Period: 2024-03-07

Cardiff Oncology, Inc.CRDF

DirectorChief Executive Officer

Transactions

Award
Stock Options
2024-03-07+510,000→ 2,170,310 total
Exercise: $3.51Exp: 2034-03-07→ Common Stock (510,000 underlying)

Footnotes (1)

[F1]25% of the shares subject to the option will vest on March 7, 2025 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person.

Documents

1 file

4
wk-form4_1709854769.xmlPrimary
FORM 4

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1

filerCIK 0001651537

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 6:39 PM ET
Size: 5.7 KB

View on SEC.gov